AR008094A1 - Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica. - Google Patents

Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica.

Info

Publication number
AR008094A1
AR008094A1 ARP970103413A ARP970103413A AR008094A1 AR 008094 A1 AR008094 A1 AR 008094A1 AR P970103413 A ARP970103413 A AR P970103413A AR P970103413 A ARP970103413 A AR P970103413A AR 008094 A1 AR008094 A1 AR 008094A1
Authority
AR
Argentina
Prior art keywords
parathyroid hormone
synthesis
preparation
pharmaceutical composition
synthetic polypeptide
Prior art date
Application number
ARP970103413A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR008094A1 publication Critical patent/AR008094A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un proceso para la síntesis de un polipéptido sintético análogo a la hormona paratiroidea (PTH) o al péptido relacionado con la hormonaparatiroidea (PTHrP), o una sal del mismo, en el que los residuos aminoácidos (22-31) seleccionados deen tre (SEQ ID Nos.; 85, 86, 26, 27, 28, 29 y 30)forman una hélice alfa anfipática, que incluye: (a) la síntesis independiente de fragmentos peptídicos precursores del polipéptido, mediante técnicas ensolución o en fase sólida; (b) la condensaciónde dichos fragmentos unos con otros para formar el producto polipeptídico deseado; y (c) la eliminaciónde los grupos protectores de aminoácidos, y proceso para la preparación de una composición farmacéutica.
ARP970103413A 1996-07-30 1997-07-28 Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica. AR008094A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2332296P 1996-07-30 1996-07-30

Publications (1)

Publication Number Publication Date
AR008094A1 true AR008094A1 (es) 1999-12-09

Family

ID=21814418

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP970103413A AR008094A1 (es) 1996-07-30 1997-07-28 Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica.
ARP990100625A AR016981A2 (es) 1996-07-30 1999-02-16 Polipeptidos sinteticos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP990100625A AR016981A2 (es) 1996-07-30 1999-02-16 Polipeptidos sinteticos

Country Status (30)

Country Link
US (1) US6849710B1 (es)
EP (1) EP0822200B1 (es)
JP (1) JP4229992B2 (es)
KR (1) KR100518982B1 (es)
CN (1) CN1293096C (es)
AR (2) AR008094A1 (es)
AT (1) ATE277080T1 (es)
AU (1) AU731160B2 (es)
BR (1) BR9704138A (es)
CA (1) CA2206008C (es)
CO (1) CO4650046A1 (es)
CZ (1) CZ239697A3 (es)
DE (1) DE69730787T2 (es)
DK (1) DK0822200T3 (es)
ES (1) ES2227639T3 (es)
HR (1) HRP970416A2 (es)
HU (1) HUP9701277A3 (es)
IL (1) IL121391A0 (es)
MA (1) MA24353A1 (es)
MX (1) MX9705719A (es)
NO (1) NO973482L (es)
NZ (1) NZ328411A (es)
PE (1) PE91998A1 (es)
PL (1) PL321391A1 (es)
SG (1) SG67408A1 (es)
TR (1) TR199700714A2 (es)
TW (1) TW505654B (es)
UY (1) UY24651A1 (es)
YU (1) YU32197A (es)
ZA (1) ZA976555B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059291A2 (en) 2002-01-10 2003-07-24 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
WO2007059470A2 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
ATE461208T1 (de) * 2006-01-17 2010-04-15 Organon Nv Selektive enzymatische hydrolyse von c-terminalen tert-butyl-peptidestern
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
CN101578093B (zh) 2006-10-03 2011-09-14 半径健康公司 骨合成代谢蛋白质的药物递送方法
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
MX363522B (es) 2013-03-21 2019-03-26 Sanofi Aventis Deutschland Síntesis de productos peptídicos que contienen hidantoína.
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
CN104530198B (zh) * 2014-12-09 2017-09-15 兰州大学 一种片段缩合制备醋酸去氨加压素的方法
KR20240110098A (ko) 2015-04-29 2024-07-12 래디어스 파마슈티컬스, 인코포레이티드 암을 치료하는 방법
CN117417263A (zh) 2017-01-05 2024-01-19 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
WO2019175173A1 (en) * 2018-03-12 2019-09-19 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of pthrp analogue
SG11202013177WA (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals Inc Polymorphic forms of rad 1901-2hcl
CN111057139B (zh) * 2018-10-17 2023-12-22 南京华威医药科技集团有限公司 一种制备特立帕肽的新工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
WO1992000753A1 (en) * 1990-07-13 1992-01-23 The Regents Of The University Of California PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN

Also Published As

Publication number Publication date
CO4650046A1 (es) 1998-09-03
HUP9701277A2 (hu) 1998-11-30
YU32197A (sh) 1999-07-28
PL321391A1 (en) 1998-02-02
ZA976555B (en) 1998-01-30
CZ239697A3 (cs) 1998-04-15
CA2206008C (en) 2008-09-23
JP4229992B2 (ja) 2009-02-25
CA2206008A1 (en) 1998-01-30
DK0822200T3 (da) 2005-01-31
HUP9701277A3 (en) 2001-02-28
DE69730787T2 (de) 2005-10-13
AR016981A2 (es) 2001-08-01
NO973482L (no) 1998-02-02
BR9704138A (pt) 1998-12-29
HRP970416A2 (en) 1998-08-31
TR199700714A2 (xx) 1998-02-21
AU731160B2 (en) 2001-03-22
ATE277080T1 (de) 2004-10-15
US6849710B1 (en) 2005-02-01
UY24651A1 (es) 2000-12-29
EP0822200B1 (en) 2004-09-22
ES2227639T3 (es) 2005-04-01
NO973482D0 (no) 1997-07-29
HU9701277D0 (en) 1997-09-29
EP0822200A1 (en) 1998-02-04
CN1293096C (zh) 2007-01-03
PE91998A1 (es) 1998-12-31
TW505654B (en) 2002-10-11
NZ328411A (en) 1998-12-23
JPH1077295A (ja) 1998-03-24
CN1174845A (zh) 1998-03-04
MA24353A1 (fr) 1998-07-01
KR100518982B1 (ko) 2006-05-29
KR980009282A (ko) 1998-04-30
AU3236297A (en) 1998-02-05
SG67408A1 (en) 1999-09-21
MX9705719A (es) 1998-02-28
IL121391A0 (en) 1998-01-04
DE69730787D1 (de) 2004-10-28

Similar Documents

Publication Publication Date Title
AR008094A1 (es) Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica.
FI89060C (fi) Foerfarnde foer framstaellning av terapeutiskt anvaendbara peptidderivat
AU1918300A (en) Amino-terminal modified parathyroid hormone (pth) analogs
AR077576A2 (es) Un peptido de telomerasa y composiciones farmaceuticas para el tratamiento contra el cancer que comprenden tales peptidos
GR3036521T3 (en) Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis.
DK262683A (da) Dynorphinamidanaloger
CO5090908A1 (es) Procedimiento para administrar peptidos insulinotropicos
KR930000536A (ko) A-c-b 프로인슐린, 그의 제조방법, 그의 용도 및 인슐린 생산을 위한 중간체
CO4890856A1 (es) CICATRIZACION DE FRACTURAS USANDO ANALOGOS DE PTHrP
AR008765A1 (es) Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del
CA2276614A1 (en) Analogs of parathyroid hormone
JPH0222292A (ja) 高カルシウム体液性因子拮抗薬
Deschodt-Lanckman et al. Cholecystokinin octa-and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase
WO2001000784A3 (fr) COMPOSE PEPTIDIQUE DERIVE D'UNE ORF DECALEE DU GENE iCE
CAULFIELD et al. Avian (chicken) parathyroid hormone: synthesis and comparative biological evaluation of the 1-34 fragment
PL355852A1 (en) Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients
DE3476666D1 (en) Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide
Rohde et al. Structure of antigenic determinants in the N-terminal region of dermatosparactic sheep procollagen type I
JPS56108750A (en) Polypeptide and its preparation
Hlaváček et al. Utilization of some non coded amino acids as isosters of peptide building blocks
RU2144038C1 (ru) Пептиды для ингибирования высвобождения пепсина, фармацевтическая композиция
AR122306A1 (es) Variantes del cnp y sus conjugados
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
KR930703345A (ko) 펩타이드의 액상 합성법
Nakagomi et al. Isolation of novel peptides, cabin-1,-2,-3, and-4, that inhibit cathepsin B from a thermolysin digest of human plasma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal